Subscribe To
Rising global uti cases and multidrug-resistant bacteria: fueling the urinary tract infection testing market to us$ 1.1 billion by 2033 | future market insights
Urinary tract infection (UTI) is a widespread infectious disease caused by bacteria, particularly complicated UTI (cUTI) due to urinary system abnorma...
August 4, 2023, 12:30 am
Metformin treatment may decrease the mortality risk in icu patients with type 2 diabetes and chf
Patients receiving intensive care often have diabetes mellitus (DM) together with chronic heart failure...
June 27, 2023, 7:02 pm
Biomea fusion presents positive clinical data from the initial cohorts of the ongoing phase ii study (covalent-111) of bmf-219 in patients with type 2 diabetes mellitus at the american diabetes associ
Eight weeks after completing treatment with BMF-219, patients with type 2 diabetes (T2D) showed an increase of C-peptide and an improvement of HOMA-B,...
June 24, 2023, 1:54 am
Biomea fusion presents positive clinical data from the initial cohorts of the ongoing phase ii study (covalent-111) of bmf-219 in patients with type 2 diabetes mellitus at the american diabetes associ
Eight weeks after completing treatment with BMF-219, patients with type 2 diabetes (T2D) showed an increase of C-peptide and an improvement of HOMA-B,...
June 24, 2023, 1:54 am
Biomea fusion presents positive clinical data from the initial cohorts of the ongoing phase ii study (covalent-111) of bmf-219 in patients with type 2 diabetes mellitus at the american diabetes associ
Eight weeks after completing treatment with BMF-219, patients with type 2 diabetes (T2D) showed an increase of C-peptide and an improvement of HOMA-B,...
June 24, 2023, 1:54 am
Biomea fusion presents positive clinical data from the initial cohorts of the ongoing phase ii study (covalent-111) of bmf-219 in patients with type 2 diabetes mellitus at the american diabetes associ
Eight weeks after completing treatment with BMF-219, patients with type 2 diabetes (T2D) showed an increase of C-peptide and an improvement of HOMA-B,...
June 24, 2023, 1:54 am
Biomea fusion presents positive clinical data from the initial cohorts of the ongoing phase ii study (covalent-111) of bmf-219 in patients with type 2 diabetes mellitus at the american diabetes associ
Eight weeks after completing treatment with BMF-219, patients with type 2 diabetes (T2D) showed an increase of C-peptide and an improvement of HOMA-B,...
June 24, 2023, 1:54 am
Biomea fusion presents positive clinical data from the initial cohorts of the ongoing phase ii study (covalent-111) of bmf-219 in patients with type 2 diabetes mellitus at the american diabetes associ
Eight weeks after completing treatment with BMF-219, patients with type 2 diabetes (T2D) showed an increase of C-peptide and an improvement of HOMA-B,...
June 24, 2023, 1:54 am
Biomea fusion presents positive clinical data from the initial cohorts of the ongoing phase ii study (covalent-111) of bmf-219 in patients with type 2 diabetes mellitus at the american diabetes associ
Eight weeks after completing treatment with BMF-219, patients with type 2 diabetes (T2D) showed an increase of C-peptide and an improvement of HOMA-B,...
June 24, 2023, 1:54 am
Pfizer v medical properties: covid-19 vaccines give pfizer an edge
Pfizer Inc Pfizer Inc. (NYSE:PFE) is a company that manufactures and markets biopharmaceutical products worldwide. They provide medications for variou...
February 19, 2022, 6:54 pm
Pfizer v medical properties: covid-19 vaccines give pfizer an edge
Pfizer Inc Pfizer Inc. (NYSE:PFE) is a company that manufactures and markets biopharmaceutical products worldwide. They provide medications for variou...
February 19, 2022, 6:54 pm
Pfizer v medical properties: covid-19 vaccines give pfizer an edge
Pfizer Inc Pfizer Inc. (NYSE:PFE) is a company that manufactures and markets biopharmaceutical products worldwide. They provide medications for variou...
February 19, 2022, 6:54 pm